212063-19-9

Basic information

• Product Name: Carbamic acid, (2-iodophenyl)-, phenylmethyl ester
• Synonyms: N-Cbz-2-iodoaniline;N-carbobenzyloxy-2-iodoaniline;N-(benzyloxycarbonyl)-2-iodoaniline;N-benzyloxycarbonyl-2-iodoaniline;N-carbobenzyloxy-o-iodoaniline;benzyl 2-(iodo)phenylcarbamate;benzyl (2-iodophenyl)carbamate
• CAS NO: 212063-19-9
• Molecular Formula: C14H12INO2
• Molecular Weight: 353.159
• Mol File: 212063-19-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Carbamic acid, (2-iodophenyl)-, phenylmethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, (2-iodophenyl)-, phenylmethyl ester(212063-19-9)
• EPA Substance Registry System: Carbamic acid, (2-iodophenyl)-, phenylmethyl ester(212063-19-9)

Safety Data

• Hazardous Substances Data: 212063-19-9(Hazardous Substances Data)

Upstream product

• 615-43-0 2-iodophenylamine 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 212063-24-6 N-carbobenzyloxy-2-[(E)-2-(p-toluenesulfonyl)ethenyl]indoline 
• 132431-12-0 N-(benzyloxycarbonyl)indoline 
• 1378521-78-8 C₁₇H₁₇BrINO₂ 
• 1378521-77-7 C₁₆H₁₅BrINO₂ 
• 3469-20-3 2,3-diphenyl-1H-indole 
• 1008303-71-6 benzyl 2,3-di-n-propylindole-1-carboxylate 
• 275356-29-1 benzyl 3-(2-methoxy-2-oxoethyl)-4-oxo-3,4-dihydro-1(2H)-quinolinecarboxylate 
• 388564-61-2 methyl N-carbobenzyloxy-2-(p-toluenesulfonyl)-1,2,3,4-tetrahydrocarbazole-4-carboxylate 
• 388564-52-1 N-carbobenzyloxy-2-[(E)-2-(p-toluenesulfonyl)ethenyl]indole 
• 388564-51-0 2-[(E)-2-(p-toluenesulfonyl)ethenyl]indole 
• 522614-63-7 methyl N-(carbobenzyloxy)carbazole-3-carboxylate 
• 522614-60-4 N-(carbobenzyloxy)-2-[(E)-2-(phenylthio)ethenyl]indole 
• 246257-97-6 N-allyl-N-(benzyloxycarbonyl)aniline 
• 61107-65-1 o-Aminobenzolphosphonsaeure-monoaethylether 

Relevant articles and documents

11a-N-Tosyl-5-deoxi-pterocarpan (LQB-223), a promising prototype for targeting MDR leukemia cell lines

Aza-deoxi-pterocarpans (1) were synthesized through palladium-catalyzed aza-arylation of dihydronaphtalen, and showed antineoplastic effect on MDR leukemic cell lines (K562, Lucena-1 and FEPS). Compounds 1c-d were prepared to identify the pharmacophoric g

Synthesis of 3-methoxycarbonylmethyl derivatives of dihydroquinolone and dihydrochromenone

-